top of page
Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
STORIES
MEETINGS
MEMBERS

Jens H. Vogel

President & COO of Mirai Bio - Former CEO of BI Fremont & Global Head of Biotech at Bayer Pharmaceuticals

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Ted Torphy

Dr. Ted Torphy brings to BioMotiv over 30 years of experience in the pharmaceutical industry with a successful record in both small-molecule and large-molecule drug discovery and preclinical development.

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Patrick Basanez

Director of GBX GROUP

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Thomas Herget

Head Silicon Valley & China Innovation Hub at Merck Group

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Uwe Gottschalk

Operating Partner at Keensight Capital - Former CSO of Lonza

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Dave Malenfant

Dave Malenfant is Director, Outreach & Partnerships, Center for Supply Chain Innovation, at the Texas Christian University Neeley School of Business in Fort Worth, TX. He has more than 25 years of experience in driving change and performance

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Jesse McCool

CSO of Bionova Scientific - Former Co-Founder & CEO of Wheeler Bio

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Angela Vollstedt

Global Director, Cell & Gene Therapies Portfolio Management at Novartis

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Behzad Mahdavi

Dr. Behzad Mahdavi is a distinguished strategic growth leader in the biopharma industry, renowned for his expertise in developing patient-centric growth strategies across various domains, including cell therapy, gene therapy, synthetic biology, personalized medicine, and life sciences. Currently, Dr. Mahdavi serves as the CEO of InnoGI Technologies and Executive Chairman at OpenCel Technologies.

With a career spanning over two decades, Dr. Mahdavi has held senior leadership roles at Lonza, Catalent Biopharma Solutions, and Ginkgo Bioworks, earning recognition in Marquis Who's Who for his outstanding contributions. His proven track record showcases his ability to drive strategies that generate significant value and foster sustainable growth in emerging biopharma fields, with a profound impact on patient outcomes.

Beyond his professional accomplishments, Dr. Mahdavi is an active participant on multiple Boards of Directors and Advisory Boards. He holds a PhD in Chemistry and an MBA and is the esteemed author of "Mastering Commercial Innovation," a comprehensive guide on translating innovative ideas into profitable growth strategies.

Highly sought after as an advisor for both technology start-ups and established enterprises, Dr. Mahdavi offers invaluable expertise in fundraising, strategic development, innovation management, sales expansion, and the commercialization of disruptive technologies.

Speakers
bottom of page